Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(5 sites)

United States

National Jewish Health, Denver, Colorado

Mayo Clinic, Rochester, Minnesota

Oregon Health & Science University, Portland, Oregon

Medical University of South Carolina, Charleston, South Carolina

University of Texas Health Science Center, Tyler, Texas